Purpose of consultancy
To contribute to data mining, cleaning and analysis to inform the development of WHO’s 2023 pre-clinical pipeline review of antibacterial treatments
Deliverables
Deliverable 1: Contribute to the development of WHO pre-clinical pipeline reviews of antibiotics and antibacterials targeting the WHO bacterial priority pathogens list (WHO BPPL):
Compile product information collected through a WHO data call, desk review and any additional sources into an Excel file. This should include product name, developer, stage (i.e., lead optimization, pre-clinical candidate, Investigational New Drug/Clinical Trial Application-enabling studies), mechanism of action, expected activity against the WHO bacterial priority pathogens list as well as the funder/s for each product.
Perform a desk review study to supplement the data submitted by developers.
Clean, proofread, and verify all data for submission and final validation by the WHO R&D Advisory Group.
Communicate with project partners to verify data quality and complement data gaps in close collaboration with the WHO IRC team.
Submit all data, including verified data set in Excel as well as supporting documents/articles and references, to WHO to be stored for future reference and pipeline report iterations.
Expected by: May 2023
Deliverable 2: Contribute to presenting the pre-clinical data collected and the analyses performed and discussing potential outstanding issues. Develop a power-point presentation with the results of the pre-clinical pipeline review. Identify potential areas for discussion. Participate in preparatory pre-meeting calls with the AG Chair.
Expected by: June 2023
Deliverable 3: Contribute to drafting sections of the antibacterial pipeline report focused on antibacterial agents in pre-clinical development. Draft sections on methodology, pre-clinical traditional and non-traditional agents, discussion and conclusion, with input from WHO IRC staff and consultants.
Expected by: August 2023
Deliverable 4: Draft a scientific article on antibacterial agents in pre-clinical development based on the above analyses, for submission to relevant peer-reviewed journals/periodicals.
Expected by: September 2023
Qualifications, experience, skills and languages
Educational Qualifications:
Essential:
Advanced degree (Ph.D) in pharmacology, immune pharmacology, clinical pharmacology, biomedical sciences, microbiology or another relevant area specific to antimicrobial resistance and infectious disease.
Experience
Essential:
Over 10 years of relevant experience in the pharmaceutical/biotechnology industry developing infectious disease treatments.
Experience in the drug development process for infectious disease treatments, particularly pre-clinical research.
Experience in planning and executing pre-clinical and clinical development project plans.
Desirable:
Experience working for the UN in an international context.
Drug development experience that spans across early target identification and validation through to regulatory submissions.
Skills/Knowledge:
Essential:
Expert knowledge of AMR, infectious diseases research, and drug development.
Knowledge of key stakeholders working in drug development for infectious disease treatments.
Proven skills in scientific writing.
Ability to work independently and in a team.
Ability to work under pressure with conflicting priorities.
Excellent interpersonal and communication skills.
Computer literacy (Microsoft office including Excel, zoom, etc.).
Closing Date: Apr 6, 2023
go to method of application »
Use the link(s) below to apply on company website.
Apply via :
